期刊论文详细信息
Journal of Pharmacological Sciences
β2-Agonist Clenbuterol Induced Changes in the Distribution of White Blood Cells in Rats
Jun Tanihata1  Kazuhiko Imaizumi1  Ken Shirato1  Norio Motohashi1  Kaoru Tachiyashiki3  Akio Tomoda2 
[1] Laboratory of Physiological Sciences, Faculty of Human Sciences, Waseda University, Japan;Department of Biochemistry, Tokyo Medical University, Japan;Department of Living and Health Sciences, Joetsu University of Education, Japan
关键词: β2-agonist;    clenbuterol;    immune-responsive system;    white blood cell;    lymphocyte;   
DOI  :  10.1254/jphs.FP0070267
学科分类:药学
来源: Nihon Yakuri Gakkai Henshuubu / Japanese Pharmacological Society
PDF
【 摘 要 】

References(42)Cited-By(18)Clenbuterol [CLE: 4-amino-α(t-butyl-amino)methyl-3,5-dichlorobenzyl alcohol] is well known as a potent β2-adrenergic agonist and non-steroidal anabolic drug, and thus it is generally used for sports doping and asthma therapy. Although the functions of immune cells such as white blood cells (WBCs) have shown to be modulated through β2-adrenoceptors, the effects of CLE on immune-responsive systems have not been elucidated systematically. Therefore, the effects of CLE on the number of WBCs were studied in rats. Male adult rats were divided into CLE-administered group and the control group to compare the number of total WBCs, neutrophils, monocytes, lymphocytes, eosinophils, and basophils. The administration (dose = 1.0 mg · kg−1 body weight · day−1, s.c.) of CLE was maintained for 30 days. CLE did not change the number of total WBCs during the experimental period. However, CLE increased significantly the number of neutrophils and monocytes, while CLE decreased drastically the number of lymphocytes and eosinophils. There was no significant change in the number of basophils between both groups. These results suggest that the administration of CLE induces drastic redistribution of WBCs in circulation without changing the number of total WBCs, and these responses of WBCs during the administration of CLE are sustained for at least 30 days.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201911300133731ZK.pdf 362KB PDF download
  文献评价指标  
  下载次数:53次 浏览次数:55次